Specialty Compared to Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia - SCOPELeukemia
Primary Objective
The primary objective of this study is to determine whether primary PC is non-inferior to specialty PC for improving quality of life (QOL) in patients with AML.
Description
This is a cluster randomized comparative effectiveness trial of primary palliative care (PC) versus specialty PC in 1150 patients with acute myeloid leukemia (AML) and their caregivers.
Details
Age
Adult
Eligibility
Hospitalized patients with high-risk Acute Myeloid Leukemia who are receiving either intensive chemotherapy or hypomethylating agents1) Hospitalized patients (age > 18 years) with high-risk AML defined as one
of the following:
- Patients with new diagnosis > 60 years of age
- An antecedent hematologic disorder
- Therapy related-disease
- Relapsed or primary refractory AML
2) Receiving treatment with either a) intensive chemotherapy (7+3) or modification of this regimen on a clinical trial, or a similar intensive regimen requiring prolonged hospitalization; or b) hypomethylating agents +/- additional agents or modification of this regimen on a clinical trial
Locations
University of Colorado Hospital
Principal Investigator
STACY FISCHER
Study ID
Protocol Number: 23-2210
More information available at ClinicalTrials.gov: NCT05237258
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers